{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:11Z","timestamp":1790742971559,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["#16SDG3070001"],"award-info":[{"award-number":["#16SDG3070001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY029751-01\u2013NEI00072"],"award-info":[{"award-number":["R01 EY029751-01\u2013NEI00072"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY030054"],"award-info":[{"award-number":["R01 EY030054"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY031631"],"award-info":[{"award-number":["P30EY031631"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00109-020-02000-y","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T19:02:45Z","timestamp":1604689365000},"page":"119-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood\u2013retinal barrier dysfunction"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-8256","authenticated-orcid":false,"given":"Amany","family":"Tawfik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyaz","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhib","family":"Alhusban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Al-Shabrawey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/OPTH.S77538","volume":"9","author":"G Malaguarnera","year":"2015","unstructured":"Malaguarnera G, Gagliano C, Salomone S, Giordano M, Bucolo C, Pappalardo A, Drago F, Caraci F, Avitabile T, Motta M (2015) Folate status in type 2 diabetic patients with and without retinopathy. Clin Ophthalmol 9:1437\u20131442","journal-title":"Clin Ophthalmol"},{"key":"2000_CR2","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"2000_CR3","first-page":"1","volume":"61","author":"KS McCully","year":"1970","unstructured":"McCully KS, Ragsdale BD (1970) Production of arteriosclerosis by homocysteinemia. Am J Pathol 61:1\u201311","journal-title":"Am J Pathol"},{"key":"2000_CR4","doi-asserted-by":"crossref","first-page":"e013934","DOI":"10.1161\/JAHA.119.013934","volume":"9","author":"AB Karger","year":"2020","unstructured":"Karger AB, Steffen BT, Nomura SO, Guan W, Garg PK, Szklo M, Budoff MJ, Tsai MY (2020) Association between homocysteine and vascular calcification incidence, prevalence, and progression in the MESA cohort. J Am Heart Assoc 9:e013934","journal-title":"J Am Heart Assoc"},{"key":"2000_CR5","doi-asserted-by":"crossref","first-page":"e01297","DOI":"10.1002\/brb3.1297","volume":"9","author":"H Zhou","year":"2019","unstructured":"Zhou H, Huang C, Liu R, Liu C, Ma C, Ren X (2019) Lack of association between serum homocysteine level and middle cerebral artery stenosis. Brain Behav 9:e01297","journal-title":"Brain Behav"},{"key":"2000_CR6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/path.5254","volume":"248","author":"C Bossenmeyer-Pourie","year":"2019","unstructured":"Bossenmeyer-Pourie C, Smith AD, Lehmann S, Deramecourt V, Sablonniere B, Camadro JM, Pourie G, Kerek R, Helle D, Umoret R, Gueant-Rodriguez RM, Rigau V, Gabelle A, Sequeira JM, Quadros EV, Daval JL, Gueant JL (2019) N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer\u2019s disease and vascular dementia. J Pathol 248:291","journal-title":"J Pathol"},{"key":"2000_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2015.09.007","volume":"450","author":"TA Ajith","year":"2015","unstructured":"Ajith TA, Ranimenon (2015) Homocysteine in ocular diseases. Clin Chim Acta 450:316\u2013321","journal-title":"Clin Chim Acta"},{"key":"2000_CR8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10792-017-0528-0","volume":"38","author":"N Dong","year":"2018","unstructured":"Dong N, Shi H, Tang X (2018) Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema. Int Ophthalmol 38:737\u2013746","journal-title":"Int Ophthalmol"},{"key":"2000_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13098-018-0362-1","volume":"10","author":"X Lei","year":"2018","unstructured":"Lei X, Zeng G, Zhang Y, Li Q, Zhang J, Bai Z, Yang K (2018) Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr 10:61","journal-title":"Diabetol Metab Syndr"},{"key":"2000_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000499916","volume":"62","author":"XW Lei","year":"2019","unstructured":"Lei XW, Li Q, Zhang JZ, Zhang YM, Liu Y, Yang KH (2019) The protective roles of folic acid in preventing diabetic retinopathy are potentially associated with suppressions on angiogenesis, inflammation, and oxidative stress. Ophthalmic Res 62:1\u201313","journal-title":"Ophthalmic Res"},{"key":"2000_CR11","doi-asserted-by":"crossref","first-page":"191497","DOI":"10.1155\/2014\/191497","volume":"2014","author":"G Malaguarnera","year":"2014","unstructured":"Malaguarnera G, Gagliano C, Giordano M, Salomone S, Vacante M, Bucolo C, Caraci F, Reibaldi M, Drago F, Avitabile T, Motta M (2014) Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. Biomed Res Int 2014:191497","journal-title":"Biomed Res Int"},{"key":"2000_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3945\/ajcn.112.057091","volume":"98","author":"B Gopinath","year":"2013","unstructured":"Gopinath B, Flood VM, Rochtchina E, Wang JJ, Mitchell P (2013) Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr 98:129\u2013135","journal-title":"Am J Clin Nutr"},{"key":"2000_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09286586.2017.1362009","volume":"25","author":"WG Christen","year":"2018","unstructured":"Christen WG, Cook NR, Chiuve SE, Ridker PM, Gaziano JM (2018) Prospective study of plasma homocysteine, its dietary determinants, and risk of age-related macular degeneration in men. Ophthalmic Epidemiol 25:79\u201388","journal-title":"Ophthalmic Epidemiol"},{"key":"2000_CR14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.oret.2017.10.001","volume":"2","author":"WG Christen","year":"2018","unstructured":"Christen WG, Chasman DI, Cook NR, Chiuve SE, Ridker PM, Buring JE (2018) Homocysteine, B vitamins, mthfr genotype, and incident age-related macular degeneration. Ophthalmol Retina 2:508\u2013510","journal-title":"Ophthalmol Retina"},{"key":"2000_CR15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajo.2006.08.032","volume":"143","author":"E Rochtchina","year":"2007","unstructured":"Rochtchina E, Wang JJ, Flood VM, Mitchell P (2007) Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol 143:344\u2013346","journal-title":"Am J Ophthalmol"},{"key":"2000_CR16","first-page":"2007","volume":"118","author":"RS Beard Jr","year":"2011","unstructured":"Beard RS Jr, Reynolds JJ, Bearden SE (2011) Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 118:2007\u20132014","journal-title":"Blood"},{"key":"2000_CR17","first-page":"34","volume":"41","author":"G Yang","year":"2002","unstructured":"Yang G, Lu J, Pan C (2002) The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus. Zhonghua Nei Ke Za Zhi 41:34\u201338","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2000_CR18","first-page":"297","volume":"10","author":"O Vaccaro","year":"2000","unstructured":"Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G (2000) Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis 10:297\u2013304","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2000_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12020-009-9218-7","volume":"36","author":"K Ukinc","year":"2009","unstructured":"Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, Yilmaz M, Kocak M (2009) Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 36:255\u2013261","journal-title":"Endocrine"},{"key":"2000_CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/112067210801800210","volume":"18","author":"E Aydin","year":"2008","unstructured":"Aydin E, Demir HD, Ozyurt H, Etikan I (2008) Association of plasma homocysteine and macular edema in type 2 diabetes mellitus. Eur J Ophthalmol 18:226\u2013232","journal-title":"Eur J Ophthalmol"},{"key":"2000_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157340209788166940","volume":"5","author":"Z Cheng","year":"2009","unstructured":"Cheng Z, Yang X, Wang H (2009) Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 5:158\u2013165","journal-title":"Curr Hypertens Rev"},{"key":"2000_CR22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1167\/iovs.12-10536","volume":"54","author":"A Tawfik","year":"2013","unstructured":"Tawfik A, Al-Shabrawey M, Roon P, Sonne S, Covar JA, Matragoon S, Ganapathy PS, Atherton SS, El-Remessy A, Ganapathy V, Smith SB (2013) Alterations of retinal vasculature in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia. Invest Ophthalmol Vis Sci 54:939\u2013949","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2000_CR23","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ajpath.2014.05.018","volume":"184","author":"A Tawfik","year":"2014","unstructured":"Tawfik A, Markand S, Al-Shabrawey M, Mayo JN, Reynolds J, Bearden SE, Ganapathy V, Smith SB (2014) Alterations of retinal vasculature in cystathionine-beta-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia. Am J Pathol 184:2573\u20132585","journal-title":"Am J Pathol"},{"key":"2000_CR24","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1038\/s41598-017-09731-y","volume":"7","author":"R Mohamed","year":"2017","unstructured":"Mohamed R, Sharma I, Ibrahim AS, Saleh H, Elsherbiny NM, Fulzele S, Elmasry K, Smith SB, Al-Shabrawey M, Tawfik A (2017) Hyperhomocysteinemia alters retinal endothelial cells barrier function and angiogenic potential via activation of oxidative stress. Sci Rep 7:11952","journal-title":"Sci Rep"},{"key":"2000_CR25","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.18632\/oncotarget.7384","volume":"7","author":"AS Ibrahim","year":"2016","unstructured":"Ibrahim AS, Mander S, Hussein KA, Elsherbiny NM, Smith SB, Al-Shabrawey M, Tawfik A (2016) Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget 7:8532\u20138545","journal-title":"Oncotarget"},{"key":"2000_CR26","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.18632\/oncotarget.24333","volume":"9","author":"K Elmasry","year":"2018","unstructured":"Elmasry K, Mohamed R, Sharma I, Elsherbiny NM, Liu Y, Al-Shabrawey M, Tawfik A (2018) Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration. Oncotarget 9:12562\u201312590","journal-title":"Oncotarget"},{"key":"2000_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/biom10030393","volume":"10","author":"NM Elsherbiny","year":"2020","unstructured":"Elsherbiny NM, Sharma I, Kira D, Alhusban S, Samra YA, Jadeja R, Martin P, Al-Shabrawey M, Tawfik A (2020) Homocysteine induces inflammation in retina and brain. Biomolecules 10:393","journal-title":"Biomolecules"},{"key":"2000_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-4835(66)80011-8","volume":"5","author":"M Shakib","year":"1966","unstructured":"Shakib M, Cunha-Vaz JG (1966) Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. Exp Eye Res 5:229\u2013234","journal-title":"Exp Eye Res"},{"key":"2000_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00146764","volume":"41","author":"JG Cunha-Vaz","year":"1976","unstructured":"Cunha-Vaz JG (1976) The blood-retinal barriers. Doc Ophthalmol 41:287\u2013327","journal-title":"Doc Ophthalmol"},{"key":"2000_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000455809","volume":"237","author":"J Cunha-Vaz","year":"2017","unstructured":"Cunha-Vaz J (2017) The blood-retinal barrier in the management of retinal disease: EURETINA award lecture. Ophthalmologica 237:1\u201310","journal-title":"Ophthalmologica"},{"key":"2000_CR31","doi-asserted-by":"crossref","first-page":"107686","DOI":"10.1016\/j.exer.2019.05.026","volume":"186","author":"H Schultz","year":"2019","unstructured":"Schultz H, Song Y, Baumann BH, Kapphahn RJ, Montezuma SR, Ferrington DA, Dunaief JL (2019) Increased serum proteins in non-exudative AMD retinas. Exp Eye Res 186:107686","journal-title":"Exp Eye Res"},{"key":"2000_CR32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","volume":"1","author":"DW Choi","year":"1988","unstructured":"Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623\u2013634","journal-title":"Neuron"},{"key":"2000_CR33","doi-asserted-by":"crossref","first-page":"G219","DOI":"10.1152\/ajpgi.00097.2006","volume":"291","author":"J Li","year":"2006","unstructured":"Li J, McRoberts JA, Ennes HS, Trevisani M, Nicoletti P, Mittal Y, Mayer EA (2006) Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol 291:G219\u2013G228","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2000_CR34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S8756-3282(98)00061-1","volume":"22","author":"AJ Patton","year":"1998","unstructured":"Patton AJ, Genever PG, Birch MA, Suva LJ, Skerry TM (1998) Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22:645\u2013649","journal-title":"Bone"},{"key":"2000_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresbull.2009.02.005","volume":"79","author":"J Singh","year":"2009","unstructured":"Singh J, Kaur G (2009) Transcriptional regulation of PSA-NCAM expression by NMDA receptor activation in RA-differentiated C6 glioma cultures. Brain Res Bull 79:157\u2013168","journal-title":"Brain Res Bull"},{"key":"2000_CR36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/jcbfm.2011.161","volume":"32","author":"JL LeMaistre","year":"2012","unstructured":"LeMaistre JL, Sanders SA, Stobart MJ, Lu L, Knox JD, Anderson HD, Anderson CM (2012) Coactivation of NMDA receptors by glutamate and D-serine induces dilation of isolated middle cerebral arteries. J Cereb Blood Flow Metab 32:537\u2013547","journal-title":"J Cereb Blood Flow Metab"},{"key":"2000_CR37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1471-4159.2010.06598.x","volume":"113","author":"A Reijerkerk","year":"2010","unstructured":"Reijerkerk A, Kooij G, van der Pol SM, Leyen T, Lakeman K, van Het Hof B, Vivien D, de Vries HE (2010) The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J Neurochem 113:447\u2013453","journal-title":"J Neurochem"},{"key":"2000_CR38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-4547(19981215)54:6<814::AID-JNR9>3.0.CO;2-3","volume":"54","author":"IA Krizbai","year":"1998","unstructured":"Krizbai IA, Deli MA, Pestenacz A, Siklos L, Szabo CA, Andras I, Joo F (1998) Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54:814\u2013819","journal-title":"J Neurosci Res"},{"key":"2000_CR39","doi-asserted-by":"crossref","first-page":"H2592","DOI":"10.1152\/ajpheart.00520.2003","volume":"285","author":"CD Sharp","year":"2003","unstructured":"Sharp CD, Hines I, Houghton J, Warren A, Jackson THT, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, Alexander JS (2003) Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol 285:H2592\u2013H2598","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2000_CR40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10072-010-0241-5","volume":"31","author":"X Liu","year":"2010","unstructured":"Liu X, Hunter C, Weiss HR, Chi OZ (2010) Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia. Neurol Sci 31:699\u2013703","journal-title":"Neurol Sci"},{"key":"2000_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.302.1.50","volume":"302","author":"C Paul","year":"2002","unstructured":"Paul C, Bolton C (2002) Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine. J Pharmacol Exp Ther 302:50\u201357","journal-title":"J Pharmacol Exp Ther"},{"key":"2000_CR42","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1167\/iovs.10-6870","volume":"52","author":"PS Ganapathy","year":"2011","unstructured":"Ganapathy PS, White RE, Ha Y, Bozard BR, McNeil PL, Caldwell RW, Kumar S, Black SM, Smith SB (2011) The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci 52:5515\u20135524","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2000_CR43","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1046\/j.1471-4159.1995.65052016.x","volume":"65","author":"PG Gunasekar","year":"1995","unstructured":"Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J Neurochem 65:2016\u20132021","journal-title":"J Neurochem"},{"key":"2000_CR44","first-page":"219","volume":"39","author":"KS McCully","year":"2009","unstructured":"McCully KS (2009) Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 39:219\u2013232","journal-title":"Ann Clin Lab Sci"},{"key":"2000_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00043798-199808000-00006","volume":"5","author":"TB Domagala","year":"1998","unstructured":"Domagala TB, Undas A, Libura M, Szczeklik A (1998) Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 5:239\u2013247","journal-title":"J Cardiovasc Risk"},{"key":"2000_CR46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","volume":"8","author":"AA Moustafa","year":"2014","unstructured":"Moustafa AA, Hewedi DH, Eissa AM, Frydecka D, Misiak B (2014) Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front Behav Neurosci 8:343","journal-title":"Front Behav Neurosci"},{"key":"2000_CR47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.molbrainres.2005.02.003","volume":"136","author":"M Tomiyama","year":"2005","unstructured":"Tomiyama M, Furusawa K, Kamijo M, Kimura T, Matsunaga M, Baba M (2005) Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus. Brain Res Mol Brain Res 136:275\u2013281","journal-title":"Brain Res Mol Brain Res"},{"key":"2000_CR48","first-page":"61","volume":"52","author":"MJ Rodman","year":"1989","unstructured":"Rodman MJ (1989) Your guide to the newest drugs. RN 52:61\u201376","journal-title":"RN"},{"key":"2000_CR49","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.92.5.1585","volume":"92","author":"M Watanabe","year":"1995","unstructured":"Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A 92:1585\u20131589","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2000_CR50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/abbs\/gmv135","volume":"48","author":"P Ju","year":"2016","unstructured":"Ju P, Cui D (2016) The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia. Acta Biochim Biophys Sin Shanghai 48:209\u2013219","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"2000_CR51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0079-6123(09)17906-2","volume":"179","author":"AJ Ramsey","year":"2009","unstructured":"Ramsey AJ (2009) NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. Prog Brain Res 179:51\u201358","journal-title":"Prog Brain Res"},{"key":"2000_CR52","doi-asserted-by":"crossref","unstructured":"Tawfik A, Mohamed R, Elsherbiny NM, DeAngelis MM, Bartoli M, Al-Shabrawey M (2019) Homocysteine: a potential biomarker for diabetic retinopathy. J Clin Med 8","DOI":"10.3390\/jcm8010121"},{"key":"2000_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0042-6989(85)90076-8","volume":"25","author":"S Remtulla","year":"1985","unstructured":"Remtulla S, Hallett PE (1985) A schematic eye for the mouse, and comparisons with the rat. Vis Res 25:21\u201331","journal-title":"Vis Res"},{"key":"2000_CR54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2008.10.096","volume":"449","author":"CR Kuhlmann","year":"2009","unstructured":"Kuhlmann CR, Zehendner CM, Gerigk M, Closhen D, Bender B, Friedl P, Luhmann HJ (2009) MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci Lett 449:168\u2013172","journal-title":"Neurosci Lett"},{"key":"2000_CR55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5301\/ejo.5000426","volume":"24","author":"G Minniti","year":"2014","unstructured":"Minniti G, Calevo MG, Giannattasio A, Camicione P, Armani U, Lorini R, Piana G (2014) Plasma homocysteine in patients with retinal vein occlusion. Eur J Ophthalmol 24:735\u2013743","journal-title":"Eur J Ophthalmol"},{"key":"2000_CR56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3389\/fphys.2018.01268","volume":"9","author":"RP Homme","year":"2018","unstructured":"Homme RP, Singh M, Majumder A, George AK, Nair K, Sandhu HS, Tyagi N, Lominadze D, Tyagi SC (2018) Remodeling of retinal architecture in diabetic retinopathy: disruption of ocular physiology and visual functions by inflammatory gene products and pyroptosis. Front Physiol 9:1268","journal-title":"Front Physiol"},{"key":"2000_CR57","first-page":"21","volume":"163","author":"GL Booth","year":"2000","unstructured":"Booth GL, Wang EE (2000) Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. CMAJ 163:21\u201329","journal-title":"CMAJ"},{"key":"2000_CR58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2017.00324","volume":"9","author":"KS McCully","year":"2017","unstructured":"McCully KS (2017) Hyperhomocysteinemia, suppressed immunity, and altered oxidative metabolism caused by pathogenic microbes in atherosclerosis and dementia. Front Aging Neurosci 9:324","journal-title":"Front Aging Neurosci"},{"key":"2000_CR59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2017.03.005","volume":"307","author":"Y Dong","year":"2017","unstructured":"Dong Y, Kalueff AV, Song C (2017) N-methyl-d-aspartate receptor-mediated calcium overload and endoplasmic reticulum stress are involved in interleukin-1beta-induced neuronal apoptosis in rat hippocampus. J Neuroimmunol 307:7\u201313","journal-title":"J Neuroimmunol"},{"key":"2000_CR60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4140\/TCP.n.2017.511","volume":"32","author":"BE Glynn-Servedio","year":"2017","unstructured":"Glynn-Servedio BE, Ranola TS (2017) AChE inhibitors and NMDA receptor antagonists in advanced Alzheimer\u2019s disease. Consult Pharm 32:511\u2013518","journal-title":"Consult Pharm"},{"key":"2000_CR61","first-page":"273","volume":"22","author":"M Merello","year":"1999","unstructured":"Merello M, Nouzeilles MI, Cammarota A, Leiguarda R (1999) Effect of memantine (NMDA antagonist) on Parkinson\u2019s disease: a double-blind crossover randomized study. Clin Neuropharmacol 22:273\u2013276","journal-title":"Clin Neuropharmacol"},{"key":"2000_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","volume":"102","author":"PJ Hallett","year":"2004","unstructured":"Hallett PJ, Standaert DG (2004) Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease. Pharmacol Ther 102:155\u2013174","journal-title":"Pharmacol Ther"},{"key":"2000_CR63","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s12035-015-9212-4","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kyles P, Kalani A, Tyagi N (2016) Hydrogen sulfide ameliorates homocysteine-induced Alzheimer\u2019s disease-like pathology, blood-brain barrier disruption, and synaptic disorder. Mol Neurobiol 53:2451\u20132467","journal-title":"Mol Neurobiol"},{"key":"2000_CR64","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2009.06207.x","volume":"110","author":"R Poddar","year":"2009","unstructured":"Poddar R, Paul S (2009) Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 110:1095\u20131106","journal-title":"J Neurochem"},{"key":"2000_CR65","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1074\/jbc.RA119.008820","volume":"294","author":"SN Deep","year":"2019","unstructured":"Deep SN, Mitra S, Rajagopal S, Paul S, Poddar R (2019) GluN2A-NMDA receptor-mediated sustained Ca(2+) influx leads to homocysteine-induced neuronal cell death. J Biol Chem 294:11154\u201311165","journal-title":"J Biol Chem"},{"key":"2000_CR66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nbd.2019.03.012","volume":"127","author":"A Jindal","year":"2019","unstructured":"Jindal A, Rajagopal S, Winter L, Miller JW, Jacobsen DW, Brigman J, Allan AM, Paul S, Poddar R (2019) Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors. Neurobiol Dis 127:287\u2013302","journal-title":"Neurobiol Dis"},{"key":"2000_CR67","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fncel.2016.00246","volume":"10","author":"DA Sibarov","year":"2016","unstructured":"Sibarov DA, Abushik PA, Giniatullin R, Antonov SM (2016) GluN2A subunit-containing NMDA receptors are the preferential neuronal targets of homocysteine. Front Cell Neurosci 10:246","journal-title":"Front Cell Neurosci"},{"key":"2000_CR68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exer.2001.1009","volume":"73","author":"P Moore","year":"2001","unstructured":"Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB (2001) Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 73:45\u201357","journal-title":"Exp Eye Res"},{"key":"2000_CR69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2014.06.021","volume":"236","author":"X Pang","year":"2014","unstructured":"Pang X, Liu J, Zhao J, Mao J, Zhang X, Feng L, Han C, Li M, Wang S, Wu D (2014) Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-kappaB signal pathway in rat vascular smooth muscle cells. Atherosclerosis 236:73\u201381","journal-title":"Atherosclerosis"},{"key":"2000_CR70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","volume":"139","author":"M Diaz-Coranguez","year":"2017","unstructured":"Diaz-Coranguez M, Ramos C, Antonetti DA (2017) The inner blood-retinal barrier: cellular basis and development. Vis Res 139:123\u2013137","journal-title":"Vis Res"},{"key":"2000_CR71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.preteyeres.2017.09.003","volume":"62","author":"M Campbell","year":"2018","unstructured":"Campbell M, Cassidy PS, O'Callaghan J, Crosbie DE, Humphries P (2018) Manipulating ocular endothelial tight junctions: applications in treatment of retinal disease pathology and ocular hypertension. Prog Retin Eye Res 62:120\u2013133","journal-title":"Prog Retin Eye Res"},{"key":"2000_CR72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/1358863x05vm626oa","volume":"10","author":"I Qureshi","year":"2005","unstructured":"Qureshi I, Chen H, Brown AT, Fitzgerald R, Zhang X, Breckenridge J, Kazi R, Crocker AJ, Stuhlinger MC, Lin K, Cooke JP, Eidt JF, Moursi MM (2005) Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med 10:215\u2013223","journal-title":"Vasc Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-02000-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-020-02000-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-02000-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:05:07Z","timestamp":1697047507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-020-02000-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-02000-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments with animals conformed to the ARVO Statement for Use of Animals in Ophthalmic and Vision Research and were done following our animal protocol approved by the Institute for Animal Care and Use Committee (IACUC) and Augusta University policies (protocol number AUP 2014-0683).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}